FOSUN HEALTH Logo

Hereditary Ataxia Diagnosis

catalogue

Hereditary Ataxia Diagnosis

Hereditary Ataxia Diagnosis

The diagnosis of hereditary ataxia rests on two facts and one test . The two facts are the inheritance pattern and the age at onset , and both are usually obtainable from the family before anyone is examined — which is why the most informative part of this assessment costs nothing and already exists. The examination establishes that the problem is coordination rather than weakness, and separates a purely cerebellar pattern from one in which the nerves and the posterior columns are involved. Imaging excludes rather than diagnoses. And the genetic test is chosen rather than exhaustive : a repeat-expansion test, a panel, or sequencing, picked because the pattern pointed at it. This page sets out each of those, the three shapes a result can take, and what a finished assessment leaves behind in writing.

Two facts, and why they decide the test

Two facts are established first, and together they decide which test is worth doing before any test is ordered. How does it run in the family? At what age did it begin?

They work because the groups differ on exactly these two axes. Adult onset with affected people in successive generations points at the dominant group, where a gene panel is the reasonable first test. Childhood or adolescent onset in a family where both parents are well points at the recessive group, where a repeat-expansion test for Friedreich ataxia is the reasonable first test. Episodes rather than a continuous decline point at the episodic ataxias, where the treatment rather than the surveillance is the answer. A wider multi-system picture points at the mitochondrial group, where a different set of investigations is used from the start.

What the two facts do not do is give the diagnosis. They decide which test is the right one rather than the largest one — and that distinction is the whole of the value here, because ordering every available test at once produces more results to explain and no more answers.

The reason they outrank the scan is not that the scan is useless. It is that the scan answers a different question: it says the cerebellum is involved and excludes what would be visible. It does not say which hereditary ataxia this is. How the pattern is recognised at home is set out on the symptoms page.

What the appointment asks, and how a family history is taken

The first appointment is largely a history, and the history here is a pedigree. What is being assembled is not a story but a chart: three generations, who was affected, at what age each became unsteady, how it progressed in each of them, and who is well.

The way it is asked matters more than the question. A general question — does anyone else in the family have this? — is usually answered no, and in this group it is answered no by families in which several people are affected. What works is going relative by relative, and asking about the descriptions families actually use: who was unsteady, who was clumsy, who was said to have a drink problem, who stopped walking distances, who used a stick early, who died of heart failure in middle age. Those are the relatives who carry the pattern, and none of them is described as having a disease.

Two questions are asked that people are frequently surprised by. The first is whether the parents are related by blood, which is asked without any implication and is the setting in which the recessive forms are most often found. The second is what has arrived outside the nervous system — the heart, glucose, the spine, hearing — because those are the features that place a family in the group carrying surveillance obligations.

What is also asked is what has already been done: which scans, in what year and with which sequences; which genetic tests, by which laboratory, and what the report actually said rather than what was understood from it. Where a previous report exists, it is the single most useful document a family can bring, and a summary of it is not a substitute.

The parts of the examination that carry the weight

Five things are done in the room, and each answers a question that no scan answers better.

Gait, stance and sitting. The person walks, turns, stops, and stands with the feet together, and then with the eyes closed. What is being established is whether the ataxia is of the limbs, of the trunk, or both — because the two are targeted differently in therapy — and how much vision is compensating.

Limb coordination. Reaching for a target, touching the nose, and rapid alternating movements. Overshoot that worsens as the target gets closer, and a tremor that appears during the movement rather than at rest, are the findings that distinguish a cerebellar tremor from a parkinsonian one.

Speech and swallowing. Speech is examined for the scanning quality that characterises cerebellar dysarthria, and where it has changed, swallowing is assessed rather than asked about. The reason is the reason given throughout this guide: the same muscles serve both, and the assessment is worth doing while it can be routine.

Reflexes, vibration and joint position sense. This is the part that separates the groups. Absent ankle reflexes together with an upgoing plantar, and loss of vibration and joint position sense, mean the peripheral nerves and the posterior columns are involved alongside the cerebellum — and that combination points at the recessive group rather than the dominant one.

The spine, the feet and the heart. Scoliosis, a high arch to the foot, and the heart are examined, because these are where the recessive forms declare themselves and because scoliosis and foot shape often precede the unsteadiness by years. This is the part of the examination most often left undone, and it is the part that carries the surveillance.

Which genetic test, and the three shapes of a result

Genetic testing here is chosen rather than exhaustive. Each test below looks at a different thing, and the pattern decides which is used first.

Test The question it answers When it is not the first test
Repeat-expansion testing Whether the specific expanded repeat responsible for Friedreich ataxia is present, where onset was in childhood or adolescence Not first where onset was in adult life with a dominant family pattern
An ataxia gene panel Whether a disease-causing variant is present in one of the many genes known to cause the dominant ataxias Not first where the pattern points clearly at the recessive group
Exome or genome sequencing A broader search, used where the pattern is unclear, where a panel has been negative, or where the picture spans several systems Not first where a targeted test would answer it, because breadth here produces more findings to interpret
Testing of relatives to check segregation Whether a variant found in one person travels with the condition in the family, which is how an uncertain result becomes a classified one Not a substitute for an explanation. It is done with counselling, and with the relatives' own consent
Cardiac and endocrine testing in the recessive group Not a genetic test. It is the surveillance the genotype dictates, performed on a schedule rather than for symptoms Not optional once the pattern points at the recessive group
Swallowing assessment where speech has changed Not a genetic test. It is the assessment that prevents the complication rather than reacting to it Not deferred to the next appointment

The three shapes a result takes. A disease-causing variant is found — which names the condition, ends the odyssey and switches surveillance on. No variant is found — which means the question has not been answered with the tests available, not that the cause is not genetic. Or a variant of uncertain significance, which means a change was found and the evidence is not yet sufficient to classify it, and which is the result most often misread in both directions. All three should be explained rather than handed over, and the explanation belongs before the sample is taken rather than after the report arrives.

What must be said about testing here: it is chosen from the pattern, and anything recommended that is not carried out within this pathway is named at the outset, before any payment is discussed. Where the right answer is that no further testing would change the management, that is said as plainly as the alternative. What changes once a name exists is set out on the treatment page.

When the test is negative, and what that changes

This is the section families come to a second opinion for, and the answer is narrower and more useful than most expect. A negative result does not mean the condition is not genetic, and it does not mean the ataxia is not real. It means no disease-causing variant was found by the test that was performed, and the tests differ greatly in what they look at and how deeply.

What it does change is the second decision rather than the first. The management of ataxia is guided by the pattern whether or not a name exists: the physiotherapy, the swallowing surveillance, the cardiac surveillance where the recessive pattern is present, and the home assessment are all indicated on the clinical picture rather than on the gene. So a negative result does not remove the plan — and where a family has been told that a negative test means nothing further can be done, that is the failure here rather than the result.

What must be separated, and frequently is not, is no variant found from a variant of uncertain significance. The first is an unanswered question. The second is a finding awaiting classification, and the way it is usually resolved is time plus segregation: re-examined at a defined interval against the evidence that has accumulated, and checked against whether it travels with the condition in the family.

Where the picture genuinely remains incomplete, the honest statement is that the question has not been answered yet, that the plan continues on the pattern, and that the question is revisited at a defined interval rather than closed. That is a real plan with a real endpoint, and it is worth more than another test ordered to fill the silence.

What a finished assessment leaves behind in writing

An assessment is not finished when the appointment ends. What should exist afterwards is a written statement of five things, and a family is entitled to ask for each of them.

First, which inheritance pattern this fits, and how confidently — including where the honest answer is that the history does not yet establish one. Second, which genetic test is the right next one, or the reasoning for why none would change the management. Third, what surveillance the pattern carries, inside the nervous system and outside it, with each item given an interval rather than a general instruction to keep an eye on it. Fourth, the score on a standard scale and the interval at which it will be repeated, so that progression is measured rather than recalled. Fifth, what the result means for the family — siblings, children and future pregnancies — with the recurrence risk stated as the definition of the inheritance mode rather than as a prediction about any individual.

Alongside it, a review at a defined interval: annually for the measured score, and on the schedule the genotype dictates for the heart and the metabolism. A vague instruction to come back if it is worse is not a plan, and it is the commonest way a slowly progressive condition in this group is left unmanaged.

A written opinion is returned within 48 hours of complete records arriving, and for a records-only review that means from the point the file is complete rather than from the point it is first sent. What treatment looks like once the pattern is named is set out on the treatment page.

Frequently Asked Questions

Do I need genetic testing, and which one?

Which one is the more useful question, because the tests look at different things and ordering all of them at once is not the same as ordering the right one. A repeat-expansion test is the right first test where the pattern points at Friedreich ataxia. A gene panel is the right first test where the pattern points at the dominant group. Exome or genome sequencing is used where the pattern is unclear, where a panel has been negative, or where the family history suggests something outside the usual. What should happen before any sample is taken is a conversation about the three shapes a result can take — a disease-causing variant found, none found, or a variant of uncertain significance — so that the report arrives into a family that already knows how to read it.

My MRI showed cerebellar atrophy. Is that the diagnosis?

It is a finding, and an important one, but it is not the diagnosis. Atrophy describes the end state of a process rather than its cause, and a long list of conditions produce it — hereditary, acquired, immune-mediated, toxic and structural among them. What the scan does is confirm that the cerebellum is the structure involved and exclude the causes that would be seen on it. What it does not do is say which hereditary ataxia this is, and that distinction is made by the family history, the examination and the genetic test rather than by the image.

What does a variant of uncertain significance mean?

It means a change was found in a gene, and that at the time of reporting there is not enough evidence to classify it as either disease-causing or harmless. It is not a diagnosis and it is not an all-clear, and it is the result most often misread in both directions. What usually happens next is not another immediate test but a defined interval at which the variant is re-examined against the evidence that has accumulated in the meantime, alongside a check of whether it segregates with the condition in the family. It should be explained when it arrives rather than handed over as a line in a report.

How is progression actually measured?

On a standard rating scale rather than on impression. The examination covers gait, stance, sitting, speech and limb coordination, each scored, and the total is what is compared between visits. The interval that is useful is a year, because the change over a shorter period is usually within the noise of a good week and a bad one. This matters practically: the two errors families make are judging by a good week, which understates progression, and by a single fall or a bad month, which overstates it. A measured score reviewed annually protects against both.

Find out which test is the right one, and what a result would mean for this family

Send a three-generation family history with the ages at which each person became unsteady, the age at which your own unsteadiness began, any previous scans with their reports, and the actual report — rather than a summary — of any genetic testing already done. Our team will return a written opinion on which inheritance pattern the description fits, which test would be the right one rather than the largest, whether the surveillance the pattern carries has been performed, and what the result would mean for siblings and children.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*